Biogen Idec to Present at the Goldman Sachs 30th Annual Healthcare Conference

Tuesday, June 9, 2009 11:55 am EDT

Dateline:

CAMBRIDGE, Mass.

Public Company Information:

NASDAQ:
BIIB
US09062X1037

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation at the Goldman Sachs 30th Annual Healthcare Conference will be webcast live via the internet, on Thursday, June 11 at 11:00 a.m. ET. To access the live webcast, please visit Biogen Idec’s homepage, www.biogenidec.com. An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com.

Contact:

Biogen Idec
Rob Jacobson, 617-679-2812
Investor Relations